How we work

Scroll

Seeding great ideas

Through our hands-on approach, we ensure that promising projects and start-up companies have the optimal conditions for success. Søren Møller

We support and build companies in two ways; through pre-seed grants or equity investments.

Pre-seed grants are awarded to early-stage, highly differentiated academic research projects with promising commercial potential. We work closely with project sponsors to help them develop and sharpen their plan and grow. We believe in challenging companies and their plans as much as possible. We drive company creation to the point where a startup is ready for a significant investment and we continue to build value in the syndicate through to exit.

The most promising early-stage biotech companies are developed and financed through our equity investments. We place great emphasis on working closely with other venture funds to syndicate our start-ups.

In addition to providing capital, we use our commercial expertise to provide projects and companies with the managerial and strategic support to steer them through the critical start-up phase. Management is key, and we are currently establishing an Entrepreneur in Residence programme with the goal of having strong management competencies available to the biotech startups in which we invest.

Through this hands-on approach, our aim is to transform innovative science into products that address unmet healthcare needs and improve the quality of life for the patient.

Novo Holdings uses cookies to ensure that we give you the best experience on our website. Read more